经导管主动脉瓣植入术后急性肾损伤与长期死亡风险
该单中心前瞻性研究纳入1086例因重度主动脉瓣狭窄行TAVI的患者,按VARC-2标准定义围术期AKI。AKI发生率为18.5%,与30天死亡率升高相关,且是长达7年长期死亡的强预测因子;AKI恢复者死亡率低于未恢复者。
要点
- TAVI围术期AKI发生率18.5%,与30天及7年死亡风险升高相关。
- AKI组7年死亡率为42.3%,非AKI组为22.7%(HR 1.71)。
- AKI恢复者死亡率低于未恢复者(38.2% vs 56.6%)。
核心结论
- TAVI围术期AKI是短期及长期(长达7年)死亡的强危险因素。
研究设计与样本
- 单中心前瞻性研究,最终分析纳入1086例连续接受TAVI的重度主动脉瓣狭窄患者。
- AKI按VARC-2标准定义:术后第一周内血清肌酐绝对升高≥0.3 mg/dL或升高>50%。
主要发现
- 201例(18.5%)发生AKI,随访期间289例死亡。
- AKI组30天死亡率为4.5%,非AKI组为1.9%,HR 3.70(95%CI 1.35-10.13)。
- AKI组7年死亡率为42.3%,非AKI组为22.7%,HR 1.71(95%CI 1.30-2.25)。
- 1年死亡率在单变量分析中AKI组更高,但多变量回归后不显著。
- 201例中189例有出院后30天内AKI恢复数据,恢复者死亡率为38.2%,未恢复者为56.6%(P=0.022)。
临床怎么用
- TAVI术后应重视围术期AKI的预防与监测,以降低短期和长期死亡风险。
- 促进AKI恢复可能改善远期预后。
局限性
- 单中心前瞻性研究。
- AKI恢复数据仅来自201例中的189例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute kidney injury (AKI) complicating transcatheter aortic valve implantation (TAVI) is relatively frequent and associated with significant morbidity. Previous studies have shown a higher 30-day and 1-year mortality risk in patients with periprocedural AKI. Our aim was to identify the prognostic impact of periprocedural AKI on long-term follow-up. METHODS: This is a single-center prospective study evaluating patients undergoing TAVI for severe aortic stenosis. AKI was defined according to the Valve Academic Research Consortium 2 definition, as an absolute increase in serum creatinine ≥0.3 mg/dL or an increase >50% within the first week following TAVI. Mortality data were compared between patients who developed AKI and those who did not. Logistic and Cox regressions were used for survival analysis. RESULTS: The final analysis included 1086 consecutive TAVI patients. AKI occurred in 201 patients (18.5%). During the follow-up period, 289 patients died. AKI was associated with an increased risk of 30-day mortality {4.5 versus 1.9% in the non-AKI group; hazard ratio [HR] 3.70 [95% confidence interval (CI) 1.35-10.13]}. Although 1-year mortality was higher in the AKI group in univariate analysis, it was not significant after a multivariate regression. AKI was a strong predictor of longer-term mortality [42.3 versus 22.7% for 7-year mortality; HR 1.71 (95% CI 1.30-2.25)]. In 189 of 201 patients we had data regarding recovery from AKI up to 30 days after discharge. In patients with recovery from AKI, the mortality rate was lower (38.2 versus 56.6% in the nonrecovery group; P = 0.022). CONCLUSIONS: Periprocedural AKI following TAVI is a strong risk factor for short-term as well as long-term mortality (up to 7 years). Therefore more effort is needed to reduce this complication.
引用
- Kliuk-Ben Bassat O, Finkelstein A, Bazan S, et al. Acute kidney injury after transcatheter aortic valve implantation and mortality risk-long-term follow-up. Nephrol Dial Transplant. 2020. PMID: 30169857. doi:10.1093/ndt/gfy264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。